GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
about
PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer.The Human Replicative Helicase, the CMG Complex, as a Target for Anti-cancer Therapy.Biomarkers could facilitate prediction of worse clinical outcome of cancer with special insight to cervical cancer.MINA53 deficiency leads to glioblastoma cell apoptosis via inducing DNA replication stress and diminishing DNA damage response
P2860
GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
GINS2 is a novel prognostic bi ...... in early-stage cervical cancer
@ast
GINS2 is a novel prognostic bi ...... in early-stage cervical cancer
@en
type
label
GINS2 is a novel prognostic bi ...... in early-stage cervical cancer
@ast
GINS2 is a novel prognostic bi ...... in early-stage cervical cancer
@en
prefLabel
GINS2 is a novel prognostic bi ...... in early-stage cervical cancer
@ast
GINS2 is a novel prognostic bi ...... in early-stage cervical cancer
@en
P2093
P2860
P356
P1433
P1476
GINS2 is a novel prognostic bi ...... in early-stage cervical cancer
@en
P2093
Fei Ouyang
Junling Liu
Libing Song
Xianqiu Wu
P2860
P304
P356
10.3892/OR.2017.5573
P50
P577
2017-04-11T00:00:00Z